BioTech Health X CEO Series: Virios Therapeutics Greg Duncan
BioTech Health X works to deliver the latest coverage and updates in the biotechnology sector. This includes providing…
Nasdaq Biotechnology Index Adds Quantum-Si (Nasdaq: QSI) Life Sciences Company
Quantum-Si (Nasdaq: QSI), a life science instrumentation firm commercializing a distinctive protein sequencing technology, has been added to…
Sigilon Therapeutics Provides Update on Strategic Reprioritization
San Francisco, California-based biotechnology firm Sigilon Therapeutics, Inc. (NASDAQ: SGTX) has announced a strategic re-prioritization to enable the…
Ortho Clinical Diagnostics Overview & Q&A Interview
Michael S. Iskra, Executive Vice President of Commercial Excellence and Strategy at Ortho Clinical Diagnostics I’d be happy…
Xontogeny CEO Chris Garabedian Exclusive Interview [September 2021]
As we expand our coverage of the biotechnology sector with the latest biotech news, our team at BioTech…
MacroGenics Announces Failure in SOPHIA Study of MARGENZA for Metastatic Breast Cancer Patients
Biopharma MacroGenics, Inc. (NASDAQ: MGNX) announced that the final overall survival (OS) analysis did not demonstrate a statistically…
Infinity Pharmaceuticals Add 2 New Members to Board of Directors
Clinical-stage biotech Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced the change of 2 new Board of Directors roles including…
Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
About Cel-Sci Corporation Cel-Sci Corporation is a publicly traded biotechnology business which develops, manufactures, and markets treatments focused…
Capricor Therapeutics To Present Final HOPE-2 Trial CAP-1002 Data for Late-Stage Duchenne Muscular Dystrophy (DMD)
Capricor Therapeutics Announces HOPE-2 Trial Data Presentation On September 2nd, Capricor Therapeutics (NASDAQ: CAPR) announced an upcoming company…
Oracle Health Raises $2.7M from Investors, Turns Down Y Combinator Funding
Innovative medtech company Oracle Health has raised over $2.7 Million from investors through the Republic platform. The company…
Denali Therapeutics Announces Scientific Journal Publication of Preclinical Proof of Concept for Protein Transport Vehicle (PTV)
Pre-clinical research published in Cell highlights new approach to treat FTD-GRN with enhanced brain uptake of progranulin through…
Istari Oncology Begins Phase 1 / Phase 2 Sub-Study To Evaluate PVSRIPO in Head and Neck Cancer Patients
Istari Oncology, Inc., a clinical-stage biotechnology firm focused on unique immunotherapy systems for the treatment of strong lumps,…
Altasciences Appoints Bruce Frank as Vice President, CDMO Operations
Altasciences introduced the appointment of Dr. Bruce Frank, PhD, as Vice President, CDMO Operations. Bruce has thirty years…
Advanced Chemotherapy Technologies Receives $4 Million NIH Grant to Pursue Pancreatic Cancer Treatment
Clinical-stage drug delivery company Advanced Chemotherapy Technologies (ACT) announced that the company has been awarded a Phase IIb…
Indapta Therapeutics Announces Data Demonstrating G-NK Cells Enhance Efficacy in Multiple Myeloma
Indapta Therapeutics, Inc. today announced the publication of new preclinical data in Blood Advances demonstrating the company’s proprietary…
PharmaCyte Biotech Announces Uplist to Nasdaq Capital Market and Public Offering
Biotechnology company PharmaCyte Biotech, Inc. (OTCQB: PMCBD), a company concentrated on creating cellular therapies for cancer cells and…
Recent Report Highlights Success in FDA Subgroup Approval & Treatment Arm Data
A recent report published by the American Association for Cancer Research titled Subgroup Analyses in Oncology Trials: Regulatory…